Cidara Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.09 | -100% | -0.1072 | -100% |
| P/S |
|
125.75 | 33.5 | 275.4% |
|
|
| P/BV |
|
0.9818 | 4.61 | -78.72% |
|
|
| P/FCF |
|
-0.4993 | 39.71 | -101.26% |
|
|
| Ev/Ebitda |
|
0.1472 | -19.46 | -100.76% |
|
|
| Ev/S |
|
-20.33 | 22.56 | -190.12% |
|
|
| Ev/FCF |
|
0.1467 | 45.47 | -99.68% |
|
|
| E/P |
|
-1.93 | 0.0164 | -11904.28% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-13811.92 | -14.42 | 95678.53% | -5558.31 | +148.49% |
| ROE |
|
-218.99 | 9.01 | -2530.45% |
|
|
| ROA |
|
-120.52 | 0.0151 | -795881.7% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-13319.76 | -26.5 | 50154.21% |
|
|
| ROCE |
|
-14.99 | 13.75 | -208.99% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0203 | -3.73 | -99.46% | -0.0807 | -74.83% |
| Nеt Debt/Ebitda |
|
1.06 | -3.19 | -133.12% |
|
|
| Debt/Ratio |
|
0.0166 | 0.1777 | -90.63% |
|
|
| Debt/Equity |
|
16.11 | 1.57 | 924.98% |
|
|
| Debt/Net Income |
|
-0.0211 | 0.8429 | -102.5% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-89.43 | 73.67 | -221.39% | ||
| Growth impulse Ebitda in 5 years |
|
145.88 | 15.28 | 854.71% | ||
| Growth impulse Net Income in 5 years |
|
134.66 | -33.08 | -507.07% | ||
| Growth impulse FCF in 5 years |
|
223.57 | -6.99 | -3298.43% | ||
| Growth impulse EPS in 5 years |
|
1435.78 | -59.11 | -2529% |
IP Score
4.12/10
